European Patient Registry for COVID-19
About this study
The COVID-19 (Coronavirus) pandemic has quickly infected hundreds of thousands of people worldwide. While many people with COVID-19 infections have mild or no symptoms, a significant proportion of patients can become quite ill. At this time, little is known about how patients with rheumatic diseases or autoimmune conditions, many of whom use medications and drugs that suppress the immune system, are affected by the virus. This Patient Registry hopes to recruit adults with rheumatic and autoimmune diseases, and parents of children with rheumatic and autoimmune diseases into the study to obtain insights about how best to prevent or treat COVID-19 in this potentially vulnerable population.